Change in Principal Officer
| TMC LIFE SCIENCES BERHAD |
| Date of change | 10 Feb 2025 |
| Name | DATO' DR AHMAD ADZUAN BIN ABDUL RAHMAN |
| Age | 48 |
| Gender | Male |
| Nationality | Malaysia |
| Type of change | Appointment |
| Designation | Group Chief Executive Officer |
Qualifications
|
|||||||||||||||||||||
| Working experience and occupation | Novotec Group Pte. Ltd. July 2023 to November 2024 Founding member and advisor IDS Medical Systems (idsMED) October 2020 to June 2023 Regional Managing Director & Executive Vice President (idsMED Group) September 2018 to September 2020 Managing Director (Malaysia) & Senior Vice President (idsMED Group); later Managing Director (Malaysia) & Executive Vice President in September 2019 Gleneagles Kuala Lumpur, Malaysia March 2015 to August 2018 Chief Executive Officer Parkway East Hospital, Singapore January 2014 to February 2015 Chief Executive Officer Parkway Laboratory Services, Singapore June 2012 to December 2013 Chief Operation Officer Eli Lilly & Co., Hong Kong January 2011 to June 2012 Asia Mid-Size Medical Advisor, Diabetes and Endocrinology International Consulting Project - Pan-European, South Africa 2010 National Health Service, South Wales, United Kingdom 2006 to 2009 Doctor in Specialist Training - Diabetes & Endocrinology National Health Service, East Yorkshire, United Kingdom 2003 to 2006 Doctor in Rotational Training - Internal Medicine National Health Service, Country Antrim, Northern Ireland, United Kingdom 2002 to 2003 Junior Doctor - General Surgery and General Medicine |
||||||||||||||||||||
| Directorships in public companies and listed issuers (if any) | Nil |
||||||||||||||||||||
| Family relationship with any director and/or major shareholder of the listed issuer | Nil |
||||||||||||||||||||
| Any conflict of interests that he/she has with the listed issuer | Nil |
||||||||||||||||||||
| Details of any interest in the securities of the listed issuer or its subsidiaries | Nil |
||||||||||||||||||||
| Remarks : |
Dato' Dr. Ahmad Adzuan bin Abdul Rahman was appointed as the Group Chief Executive Officer of TMC Life Sciences Berhad and Regional Senior Director of Thomson Medical Group on 10 February 2025. |
Announcement Info
| Company Name | TMC LIFE SCIENCES BERHAD |
| Stock Name | TMCLIFE |
| Date Announced | 10 Feb 2025 |
| Category | Change in Principal Officer |
| Reference Number | C04-20012025-00003 |